30-Country IVD Market Atlas (In Vitro Diagnostic Markets for US, China, Germany, UK, Saudi Arabia, India, UAE, France, Vietnam, Turkey and 20 Other Countries)

    Published: October 27, 2023 | Price: $5,000.00 – $10,000.00

    In vitro diagnostics is a global market estimated to consist of over $120 billion. With less than half that revenue earned in the United States, an assessment of regional and country IVD markets is needed for successful business planning.  Kalorama's 30 Country IVD Market Atlas report is designed to provide you with international market detail at the country-level to help improve your forecast modeling and planning. Whether you need Latin America, Middle East, APAC or Eastern Europe, this report has...
    The Worldwide Market for In Vitro Diagnostic Tests, 16th Edition

    Published: August 24, 2023 | Price: $8,750.00 – $17,500.00

    "The most trusted and essential report on the global IVD industry."   For Two Decades, One Volume Has Offered Complete Coverage of the IVD Industry The 16th edition of Kalorama’s Worldwide Market for In Vitro Diagnostic Tests is a must have for anyone interested or involved in the IVD industry.  Having a guide for the state of IVD and its future is a vital part of making well-informed decisions. The 16th edition of Kalorama’s Worldwide Market for In Vitro Diagnostic...
    The Market and Future Potential for Molecular Point of Care (mPOC), 2023

    Published: February 7, 2023 | Price: $5,000.00 – $10,000.00

    This report is an essential tool for understanding the size and growth opportunity in molecular POC.  Molecular point of care (mPOC) has gone from novel trend to significant contributor to the market.  The instruments sold by Abbott, BioMérieux, Cepheid and increasingly, a host of other companies, are a significant contributor to the IVD POC market.  Knowing these markets is essential to knowing the opportunity in point of care testing and microbiology IVD. Since 2013, Kalorama has been producing a dedicated...
    World Market for Cancer Diagnostics

    Published: November 22, 2021 | Price: $9,000.00 – $12,000.00

    Cancer testing is maturing from personalized medicine to precision medicine, where protein and molecular biomarkers are essential for precise diagnosis, therapy selection, therapy monitoring and early detection of cancer recurrence.  The World Market for Cancer Diagnostics, as well as relevant industry merger data provided by Kalorama Information, provides authoritative and complete analysis of the cancer testing industry, with expert market sizing and opportunity assessment. Segment markets for cancer testing are comprehensively covered in Kalorama Information’s World Market for Cancer Diagnostics. ...
    Companion Diagnostics in the COVID-19 Era: Market Analysis and Opportunities

    Published: June 17, 2020 | Price: $6,000.00 – $12,000.00

    Kalorama Information's report provides a comprehensive market analysis and business planning tool for the market for tests that are aligned with a pharmaceutical treatment.  Especially in oncology, companion diagnostics are rising to the forefront of pharmaceutical development and treatment. Companion diagnostics increase the probability of clinical success by identifying patients with the presence of biomarkers or disease-specific therapeutic targets that can dramatically improve outcomes.   Companion diagnostics can also decrease costs by identifying the patient population that will most likely benefit...